| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Compounded Medications | 2024-12-02 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Motixafortide (Aphexda) | 2024-12-02 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Isatuximab-irfc (Sarclisa) | 2024-12-02 |
| BCBS Highmark Penn Medicare Advantage | Motixafortide (Aphexda) | 2024-12-02 |
| BCBS Highmark NY and West NY | Laboratory Testing: Medical Necessity | 2024-12-02 |
| BCBS Highmark NY and West NY | General Approach to Genetic Testing | 2024-12-02 |
| BCBS Highmark NY and West NY | Liver Fibrosis Laboratory Tests | 2024-12-02 |
| BCBS Highmark NY and West NY | Genetic Testing for Epilepsy | 2024-12-02 |
| BCBS Highmark NY and West NY | Pediatric Panel Testing Guidelines | 2024-12-02 |
| BCBS Highmark NY and West NY | Genetic Testing for Autism | 2024-12-02 |